Camurus AB (FRA:7CA)
€ 47.78 0.34 (0.72%) Market Cap: 2.79 Bil Enterprise Value: 2.60 Bil PE Ratio: 71.89 PB Ratio: 12.20 GF Score: 83/100

Nine Months 2020 Camurus AB Earnings Call Transcript

Nov 05, 2020 / 01:00PM GMT
Release Date Price: €18.98 (+4.40%)
Operator

Ladies and gentlemen, welcome to the Camurus Q3 report for 2020. Today, I am pleased to present the President and CEO, Fredrik Tiberg. (Operator Instructions) Speakers, please begin.

Fredrik Tiberg;publ;CEO
Camurus AB;President, Head of Research & Director

()- -

Thank you so much. Good afternoon, everyone, and welcome to our third quarter presentation. Hope you're all doing well in these very unusual COVID-19 times.

Before I go into the presentation, I just want to alert you to our forward-looking statements on Slide #2. And with that, moving forward to Slide #3. So in today's call, we will update you on our continued business progress with the commercialization of Buvidal as well as provide a brief update on key R&D programs. We will finish off with key takeaways and a Q&A session. With me in today's call is our Chief Commercial Officer, Richard Jameson; and our Chief Financial Officer, Eva Pinotti-Lindqvist.

So let's move to Slide 4 and some highlights during the third quarter. You have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot